Identification and Characterization of a Transmembrane Isoform of CD160 (CD160-TM), a Unique Activating Receptor Selectively Expressed upon Human NK Cell ActivationJérôme Giustiniani(Inserm), Anne Marie‐Cardine(Inserm)The Journal of ImmunologyJanuary 1, 200910.4049/jimmunol.182.1.63Cited by 59SaveCiteExport RISWatch citationsRelated PapersIL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells|Scientific Reports|2015|56IL-17E synergizes with EGF and confers<i>in vitro</i>resistance to EGFR-targeted therapies in TNBC cells|Oncotarget|2016|29